17 days ago
TBPH
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 4%
#200 out of 5150 analysts
Average Return
+36.95%
Win Rate
64%48 out of 75
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cymabay Therapeutics IncCBAY | +262.63% | $8.91 | $32.31 | 2023-03-09 - 2024-03-08 | Strong Buy |
Prometheus Biosciences IncRXDX | +233.20% | $60.00 | $199.92 | 2022-10-02 - 2023-06-15 | Strong Buy |
Cymabay Therapeutics IncCBAY | +212.31% | $10.40 | $32.48 | 2023-05-15 - 2024-03-21 | Strong Buy |
Cymabay Therapeutics IncCBAY | +199.91% | $10.83 | $32.48 | 2023-05-01 - 2024-03-21 | Strong Buy |
Cymabay Therapeutics IncCBAY | +193.67% | $11.06 | $32.48 | 2023-07-04 - 2024-03-21 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
19 days ago
CGEM
a month ago
RNAC
a month ago
ORKA
2 months ago
ABVX
2 months ago
CLYM
3 months ago
MAZE
6 months ago
TBPH
a year ago
OTLK
a year ago
VRDN
a year ago
VRDN
a year ago
PTGX
2 years ago
SYRE
2 years ago
CBAY
2 years ago
CBAY
2 years ago
CBAY
3 years ago
KROS
3 years ago
RXDX
3 years ago
RXDX
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Akebia Therapeutics IncAKBA | 3 | Strong Buy | $5.00 | +201.20% | Reiterates | 11 days ago |
Theravance Biopharma IncTBPH | 3 | Strong Buy | $40.00 | +120.14% | Maintains | 17 days ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $38.00 | +218.79% | Maintains | 19 days ago |
Rezolute IncRZLT | 4 | Strong Buy | $17.00 | +844.44% | Reiterates | 23 days ago |
Cartesian Therapeutics IncRNAC | 2 | Strong Buy | $44.00 | +416.43% | Maintains | a month ago |
Oruka Therapeutics IncORKA | 3 | Strong Buy | $63.00 | +108.75% | Maintains | a month ago |
Connect Biopharma Holdings LtdCNTB | 2 | Strong Buy | $10.00 | +300.00% | Reiterates | a month ago |
Liquidia CorpLQDA | 4 | Strong Buy | $49.00 | +46.79% | Reiterates | a month ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +88.80% | Reiterates | a month ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -14.00% | Reiterates | 2 months ago |
Climb Bio IncCLYM | 3 | Strong Buy | $8.00 | +166.67% | Reiterates | 2 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $15.00 | +240.14% | Maintains | 2 months ago |
Apogee Therapeutics IncAPGE | 2 | Strong Buy | $115.00 | +49.20% | Reiterates | 2 months ago |
Jade Biosciences IncJBIO | 4 | Strong Buy | $28.00 | +86.92% | Initiates Coverage On | 2 months ago |
Abivax SaABVX | 3 | Strong Buy | $120.00 | -4.42% | Maintains | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Hold | $85.00 | +474.71% | Downgrades | 2 months ago |
Avalo Therapeutics IncAVTX | 2 | Strong Buy | $40.00 | +115.05% | Reiterates | 2 months ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $100.00 | +82.82% | Reiterates | 3 months ago |
Spyre Therapeutics IncSYRE | 3 | Strong Buy | $70.00 | +108.21% | Reiterates | 3 months ago |
Maze Therapeutics IncMAZE | 3 | Strong Buy | $37.00 | -4.79% | Maintains | 3 months ago |
Outlook Therapeutics IncOTLK | 4 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Anaptysbio IncANAB | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 2 years ago |
Cymabay Therapeutics IncCBAY | 7 | Strong Buy | $24.00 | N/A | Maintains | 2 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 3 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.